Logo Image
|Articles|May 22, 2023

Infectious Disease Pharmacists Day 2023: Our Top Stories

Author(s)Nina Cosdon

Today, we celebrate the crucial role of infectious disease pharmacists in combating infectious diseases and promoting patient safety.

Today, May 22, is the third annual National Infectious Disease Pharmacists Day. This day was designated to honor the remarkable efforts of infectious disease pharmacists across the country.

These specialized pharmacists work collaboratively with healthcare teams to develop treatment plans, monitor drug interactions, and provide valuable insights on emerging and challenging infectious diseases. Contagion acknowledges their significant contributions to patient care and public health with our top 5 stories by and for infectious disease pharmacists.

Related to this article

View more
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Read more
Ceftriaxone Safety: Separating Signal From Risk
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Read more
Treatment of Latent Tuberculosis in a Trice
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Read more